| 前收盘价格 | 3.90 |
| 收盘价格 | 3.92 |
| 成交量 | 2,310,402 |
| 平均成交量 (3个月) | 2,464,648 |
| 市值 | 1,142,788,096 |
| 市盈率 (P/E TTM) | 37.60 |
| 预期市盈率 (P/E Forward) | 41.15 |
| 价格/销量 (P/S) | 5.32 |
| 52周波幅 | |
| 利润日期 | 5 Aug 2025 - 11 Aug 2025 |
| 营业毛利率 | 10.12% |
| 营业利益率 (TTM) | 31.65% |
| 稀释每股收益 (EPS TTM) | 0.100 |
| 季度收入增长率 (YOY) | 18.20% |
| 季度盈利增长率 (YOY) | 23.80% |
| 流动比率 (MRQ) | 2.36 |
| 营业现金流 (OCF TTM) | 29.43 M |
| 杠杆自由现金流 (LFCF TTM) | 39.45 M |
| 资产报酬率 (ROA TTM) | 10.97% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 看跌 |
| Biotechnology (全球的) | 混合的 | 看跌 | |
| 股票 | MannKind Corporation | 看跌 | 看涨 |
AIStockmoo 评分
3.0
| 分析师共识 | 3.0 |
| 内部交易活动 | NA |
| 价格波动 | 4.5 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | 2.0 |
| 平均 | 3.00 |
|
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Growth |
| 内部持股比例 | 1.86% |
| 机构持股比例 | 58.64% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Nitorum Capital, L.P. | 31 Mar 2025 | 7,785,702 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 15.00 (Oppenheimer, 298.94%) | 购买 |
| 中 | 10.50 (179.26%) | |
| 低 | 8.00 (RBC Capital, 112.77%) | 购买 |
| 平均值 | 11.00 (192.55%) | |
| 总计 | 4 购买 | |
| 平均价格@调整类型 | 5.17 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Oppenheimer | 05 Sep 2025 | 15.00 (298.94%) | 购买 | 5.34 |
| Wells Fargo | 03 Sep 2025 | 10.00 (165.96%) | 购买 | 5.51 |
| HC Wainwright & Co. | 02 Sep 2025 | 11.00 (192.55%) | 购买 | 5.74 |
| 16 Jul 2025 | 9.00 (139.36%) | 购买 | 3.96 | |
| RBC Capital | 26 Aug 2025 | 8.00 (112.77%) | 购买 | 4.07 |
| 07 Aug 2025 | 7.00 (86.17%) | 购买 | 3.43 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合